AbbVie acquires Botox-maker Allergan in’turning point’deal

摘要

AbbVie,the biopharmaceutical company,has acquired Allergan in a purchase that includes Allergan's global aesthetics business,comprising injectables brands Botox and Juvederm,as well as CoolSculpting,which Allergan acquired in 2017.Richard Gonzalez,Chairman and CEO of AbbVie,said:”We are pleased to reach this important milestone for the company,its employees,shareholders and the patients we serve.”